Compare · AONC vs CHE
AONC vs CHE
Side-by-side comparison of American Oncology Network Inc. (AONC) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AONC and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE carries a market cap of $7.11B.
- CHE has hit the wire 7 times in the past 4 weeks while AONC has been quiet.
- CHE has more recent analyst coverage (6 ratings vs 0 for AONC).
- Company
- American Oncology Network Inc.
- Chemed Corp
- Price
- -
- -
- Market cap
- -
- $7.11B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 7
- Recent ratings
- 0
- 6
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest AONC
- SEC Form 10-K filed by American Oncology Network Inc.
- Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah
- SEC Form 15-15D filed by American Oncology Network Inc.
- Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
- Amendment: American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation
- SEC Form EFFECT filed by American Oncology Network Inc.
- SEC Form S-8 POS filed by American Oncology Network Inc.
- SEC Form POS AM filed by American Oncology Network Inc.
Latest CHE
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
- VP and Chief Legal Officer Judkins Brian C exercised 6,786 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 5,878 units of Capital Stock, increasing direct ownership by 37% to 3,344 units (SEC Form 4)
- CEO - Vitas Healthcare Wherley Joel L exercised 2,599 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 2,270 units of Capital Stock, increasing direct ownership by 39% to 1,181 units (SEC Form 4)
- Chemed Corporation Declares Quarterly Dividend of 70 Cents
- President and CEO Mcnamara Kevin J covered exercise/tax liability with 19,802 units of Capital Stock, sold $1,079,020 worth of Capital Stock (2,000 units at $539.51) and exercised 2,001 units of Capital Stock at a strike of $445.35, decreasing direct ownership by 22% to 70,418 units (SEC Form 4)
- Director Grace Patrick P sold $101,080 worth of Capital Stock (190 units at $532.00), decreasing direct ownership by 5% to 3,533 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports Second-Quarter 2026 Results